Anticoagulation in CRRT: Systemic or regional?

H. M. Oudemans-Van Straaten

doi:10.1007/0-387-35096-9_64

Anticoagulation in CRRT: Systemic or regional?

H. M. Oudemans-Van Straaten^*

^*Corresponding author for this work

Intensive care medicine

Research output: Chapter in Book/Report/Conference proceeding › Chapter › Academic › peer-review

Abstract

During continuous renal replacement therapy (CRRT), anticoagulation of the extra-corporeal circuit is generally required in order to prevent clotting of the circuit, to preserve filter performance, optimize circuit survival and prevent loss of blood due to circuit clotting.

Original language	English
Title of host publication	Intensive Care Medicine
Subtitle of host publication	Annual Update 2006
Publisher	Springer New York
Pages	690-696
Number of pages	7
ISBN (Print)	0387301569, 9780387301563
DOIs	https://doi.org/10.1007/0-387-35096-9_64
Publication status	Published - 1 Dec 2007

Access to Document

10.1007/0-387-35096-9_64

Cite this

@inbook{2cb10f6e6d104a53b460b54026d42fc8,

title = "Anticoagulation in CRRT: Systemic or regional?",

abstract = "During continuous renal replacement therapy (CRRT), anticoagulation of the extra-corporeal circuit is generally required in order to prevent clotting of the circuit, to preserve filter performance, optimize circuit survival and prevent loss of blood due to circuit clotting.",

author = "{Oudemans-Van Straaten}, {H. M.}",

year = "2007",

month = dec,

day = "1",

doi = "10.1007/0-387-35096-9_64",

language = "English",

isbn = "0387301569",

pages = "690--696",

booktitle = "Intensive Care Medicine",

publisher = "Springer New York",

address = "United States",

}

TY - CHAP

T1 - Anticoagulation in CRRT

T2 - Systemic or regional?

AU - Oudemans-Van Straaten, H. M.

PY - 2007/12/1

Y1 - 2007/12/1

N2 - During continuous renal replacement therapy (CRRT), anticoagulation of the extra-corporeal circuit is generally required in order to prevent clotting of the circuit, to preserve filter performance, optimize circuit survival and prevent loss of blood due to circuit clotting.

AB - During continuous renal replacement therapy (CRRT), anticoagulation of the extra-corporeal circuit is generally required in order to prevent clotting of the circuit, to preserve filter performance, optimize circuit survival and prevent loss of blood due to circuit clotting.

UR - http://www.scopus.com/inward/record.url?scp=84892223029&partnerID=8YFLogxK

U2 - 10.1007/0-387-35096-9_64

DO - 10.1007/0-387-35096-9_64

M3 - Chapter

AN - SCOPUS:84892223029

SN - 0387301569

SN - 9780387301563

SP - 690

EP - 696

BT - Intensive Care Medicine

PB - Springer New York

ER -

Anticoagulation in CRRT: Systemic or regional?

Abstract

Access to Document

Other files and links

Cite this